A randomised, placebo-controlled trial of Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia in chronic kidney disease (2011-2015)
Experts
Professor
David Johnson
Affiliate of Centre for Health Services Research
Centre for Health Services Research
Faculty of Health, Medicine and Behavioural Sciences
NHMRC Leadership Fellow
Centre for Health Services Research
Faculty of Health, Medicine and Behavioural Sciences